Nucleic acid Construct
US11214815B2 · kind B2 · utility
0Cited by
32References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2014 |
| Grant date | Jan 4, 2022 |
| Priority date | — |
| Expiry date | Oct 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A promoter for high level and sustained expression is provided which can be used for gene expression of chosen sequences in general. In particular, a nucleic acid construct comprising a hCEF1 promoter operably linked to a sequence for expression is provided, where the hCEF1 promoter comprises: (i) a human CMV enhancer operably linked to a human EFI a promoter; (ii) a functional fragment of (i); or (ii) a functional variant of (i) or (ii).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.